Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

274 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
Friedrich MG, Erbersdobler A, Schwaibold H, Conrad S, Huland E, Huland H. Friedrich MG, et al. J Urol. 2000 Mar;163(3):1039-42. J Urol. 2000. PMID: 10688045 Clinical Trial.
Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer.
Friedrich MG, Toma MI, Hellstern A, Pantel K, Weisenberger DJ, Noldus J, Huland H. Friedrich MG, et al. BJU Int. 2003 Dec;92(9):911-4. doi: 10.1111/j.1464-410x.2003.04528.x. BJU Int. 2003. PMID: 14632845
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers].
Hautmann SH, Schroeder GL, Civantos F, Duncan RC, Gnann R, Friedrich MG, Hellstern A, Huland H, Soloway MS, Lokeshwar VB. Hautmann SH, et al. Among authors: friedrich mg. Urologe A. 2001 Mar;40(2):121-6. doi: 10.1007/s001200050449. Urologe A. 2001. PMID: 11315586 German.
Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer.
Hautmann SH, Lokeshwar VB, Schroeder GL, Civantos F, Duncan RC, Gnann R, Friedrich MG, Soloway MS. Hautmann SH, et al. Among authors: friedrich mg. J Urol. 2001 Jun;165(6 Pt 1):2068-74. doi: 10.1097/00005392-200106000-00072. J Urol. 2001. PMID: 11371930
p53 in noncancerous bladder mucosa as a marker of disease recurrence in patients with superficial transitional cell carcinoma of the bladder.
Friedrich MG, Schwaibold H, Wintzer O, Pichlmeier U, Huland H. Friedrich MG, et al. Urol Oncol. 1997 Jul-Aug;3(4):125-31. doi: 10.1016/s1078-1439(98)00018-0. Urol Oncol. 1997. PMID: 21227117
[Cystectomy for indications other than bladder cancer].
Hautmann S, Felix-Chun KH, Currlin E, Friedrich MG, Dose Schwarz J, Langwieler T, Conrad S, Huland H. Hautmann S, et al. Among authors: friedrich mg. Urologe A. 2004 Feb;43(2):172-7. doi: 10.1007/s00120-003-0485-2. Urologe A. 2004. PMID: 14991119 Clinical Trial. German.
Cyclooxygenase-2 promotes angiogenesis in pTa/T1 urothelial bladder carcinoma but does not predict recurrence.
Friedrich MG, Toma MI, Petri S, Huland H. Friedrich MG, et al. BJU Int. 2003 Sep;92(4):389-92. doi: 10.1046/j.1464-410x.2003.04345.x. BJU Int. 2003. PMID: 12930427
Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.
Friedrich MG, Blind C, Milde-Langosch K, Erbersdobler A, Conrad S, Löning T, Hammerer P, Huland H. Friedrich MG, et al. Eur Urol. 2001 Nov;40(5):518-24. doi: 10.1159/000049829. Eur Urol. 2001. PMID: 11752859
Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder.
Friedrich MG, Riethdorf S, Erbersdobler A, Tiemer C, Schwaibold H, Sölter JK, Huland E, Riethdorf L, Conrad S, Hammerer PG, Huland H. Friedrich MG, et al. Eur Urol. 2001 Feb;39(2):159-66. doi: 10.1159/000052431. Eur Urol. 2001. PMID: 11223675
Numerical aberrations of chromosome 8 and allelic loss at 8p in non-muscle-invasive urothelial carcinomas of the urinary bladder.
Erbersdobler A, Kaiser H, Friedrich MG, Henke RP. Erbersdobler A, et al. Among authors: friedrich mg. Eur Urol. 2000 Nov;38(5):590-6. doi: 10.1159/000020336. Eur Urol. 2000. PMID: 11096241
274 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page